Murtaja, Ahmed; Eyol, Ergul; Jiang Xiaoqi; Berger, Martin R.; Adwan, Hassan
(Spandıdos publ ltd, pob 18179, athens, 116 10, greece, 2018)
Pancreatic ductal adenocarcinoma (PDAC) has one of the poorest prognoses of all malignancy types. To improve the survival of patients with PDAC, the development of novel anticancer agents is warranted. Riproximin (Rpx) is ...